πŸ‡ΊπŸ‡Έ FDA
Patent

US 7943580

Polypeptide and the use thereof

granted A61KA61K38/17A61P

Quick answer

US patent 7943580 (Polypeptide and the use thereof) held by Takeda Pharmaceutical Company Limited expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/17, A61P, A61P1/00, A61P1/04